Company Quick10K Filing
Abbott
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$84.22 1,764 $148,579
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-11-19 Other Events, Exhibits
8-K 2019-11-12 Other Events
8-K 2019-11-12 Officers, Amend Bylaw, Exhibits
8-K 2019-10-11 Other Events
8-K 2019-09-09 Officers, Amend Bylaw, Exhibits
8-K 2019-07-17 Earnings, Exhibits
8-K 2019-06-20 Officers
8-K 2019-04-26
8-K 2019-04-17 Earnings, Exhibits
8-K 2019-02-24 Leave Agreement, Off-BS Arrangement, Other Events
8-K 2019-01-23 Earnings, Exhibits
8-K 2018-11-30 Enter Agreement, Leave Agreement, Off-BS Arrangement
8-K 2018-11-14 Officers
8-K 2018-10-28 Leave Agreement, Off-BS Arrangement, Other Events
8-K 2018-10-17 Earnings, Exhibits
8-K 2018-10-11 Officers
8-K 2018-09-27 Enter Agreement, Leave Agreement, Off-BS Arrangement, Off-BS Arrangement, Other Events, Exhibits
8-K 2018-09-18 Regulation FD
8-K 2018-07-18 Earnings, Exhibits
8-K 2018-06-22 Off-BS Arrangement, Other Events
8-K 2018-06-08 Officers, Amend Bylaw, Exhibits
8-K 2018-04-27
8-K 2018-04-18 Earnings, Exhibits
8-K 2018-03-22 Leave Agreement, Off-BS Arrangement, Other Events
8-K 2018-01-24 Earnings, Exhibits

Abbott Financials

-

ABT Metrics, Comps, Filings


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Quarter)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Merck (MRK) 217,623 83,965 56,330 44,368 31,007 9,370 16,585 233,734
GlaxoSmithKline (GSK) 200,316 58,066 54,394 0 0 0 0 225,704
Novartis (NVS) 197,050 145,563 66,871 0 0 0 0 193,929
Pfizer (PFE) 249,913 156,199 96,274 53,657 42,879 12,674 16,080 286,383
Abbott (ABT) 149,087 68,427 36,741 30,935 17,651 2,895 7,217 164,940
Beigene (BGNE) 98,573 2,150 579 434 383 -664 -642 97,723
Eli Lilly (LLY) 106,241 38,666 35,809 23,229 17,810 7,843 9,937 117,668
AbbVie (ABBV) 100,912 57,142 65,708 32,624 25,254 4,118 7,085 127,359
Bristol Myers Squibb (BMY) 73,829 55,163 39,012 23,857 12,640 6,226 8,365 69,858
Celgene (CELG) 67,154 39,183 29,132 16,354 15,736 5,271 7,702 79,730
Zoetis (ZTS) 54,569 10,986 8,575 6,046 4,046 1,375 2,291 59,314
GW Pharmaceuticals (GWPH) 64,239 843 114 114 100 -50 -41 63,656
Sanofi (SNY) 52,845 111,408 0 0 0 0 52,184
Allergan (AGN) 54,767 123,846 38,273 15,678 13,341 -5,356 939 75,841
Vertex Pharmaceuticals (VRTX) 46,842 7,033 1,964 3,454 2,990 2,355 2,569 43,540
Regeneron Pharmaceuticals (REGN) 35,984 13,174 3,418 7,237 0 2,069 2,295 34,925
Alexion Pharmaceuticals (ALXN) 28,246 14,568 4,404 4,499 3,191 1,334 1,835 28,827
Hutchison China Meditech (HCM) 1,632 532 120 0 0 0 0 1,573
Biomarin Pharmaceutical (BMRN) 15,774 4,393 1,432 1,533 1,213 -110 24 16,336
Mylan (MYL) 9,779 31,817 19,914 11,245 3,793 34 2,748 22,896

Balance Sheet ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash6,8134,3467,0537,99710,8024,3735,5722,8823,4752,0603,5703,6134,0633,2264,0483,1325,0013,3342,5782,50018,6208,7069,67511,0129,4073,8573,0657,3693,8443,0223,137
Accounts Receivable7,6847,6606,7686,9497,6133,9183,9393,8833,9863,8834,0563,6183,5863,4813,5533,4603,4183,4303,5673,3203,2484,5104,6334,8005,2495,3565,1925,2715,1825,3455,548
Inventory3,2843,5493,5183,8143,7922,7102,7252,8042,6932,7752,8232,6962,6432,6232,7352,6332,5992,7862,8132,6132,4343,9953,6033,4833,6013,8263,7143,7813,7964,0854,352
PP&E18,01718,37918,21018,63018,92912,41712,52012,71412,87013,00513,09612,69412,63212,25112,43312,52812,38312,70912,71212,45212,36614,17214,47614,69815,26515,55615,30915,52015,70615,90516,331
Assets60,27762,41661,86063,25867,23542,68742,90344,13242,95341,66241,47542,51441,27543,09544,12541,72541,24739,63739,83139,49752,66670,88771,15172,24876,25070,90868,41571,63767,17367,61068,427
Accounts Payable1,7211,7271,5191,6051,7971,0881,0421,0091,0261,0741,0629651,0641,0121,0001,0071,0811,0531,1531,0511,1781,4811,6671,8582,4022,4762,5032,7302,9753,0453,222
Long-Term Debt
Liabilities35,83736,96237,37336,24440,51420,09820,56720,43617,78218,27217,87319,62619,74921,22121,11720,61420,03618,91519,15618,72132,12839,52539,54940,21645,35339,50937,83840,93236,64936,68536,741
Stockholders' Equity24,44025,45424,48727,01426,72122,58822,33623,69625,17123,39023,60222,88821,52621,87423,00821,11121,21120,72220,67520,77620,53831,36231,60232,03230,89731,39930,57730,70530,52430,92531,686
Income Statement ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue10,3779,4579,8079,77310,8375,3785,4465,3695,6555,2445,5515,1045,3564,8975,1705,1505,1884,8855,3335,3025,3336,3357,6706,8297,5897,3907,7677,6567,7657,5357,979
Cost of Revenue3,8384,0592,8112,5002,3492,4333,8233,2823,1663,1913,1603,279
Gross Profit6,5406,7782,8442,8562,8392,9003,7664,4854,4904,0864,3754,700
R&D1,0061,0111,164346363357386387335307356313345378369379348352343547708562613589575574562672577
SG&A3,0002,9442,9221,7861,7141,7351,7011,7621,7881,6031,6441,7371,7271,6661,6551,6981,7371,6281,6092,4242,9282,0992,4622,5422,4662,3772,3592,4782,434
Tax271279-7010125-14414884277278170124200118135-54116178110350197651,4382259166292-4096
Net Income1,6191,0535893754665399052,292784580767316615-3297984191,031603-8284187335636546721,006
Cash Flow ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating4607175221,6253369001,2011,23829411,195828-939091,2171,1705741,3512,0051,6401,1081,2442,1831,7657121,060
Cash Investing-2,10836-2,697840-5951,228-825-10-205242-1,1971,566226-1,470-5541,550-6,154-6-306-3,152-238-299-323-496-396-498
Cash Financing-4,733465-559-1,869-1,152-619-271-700-550-374-815-497-1,432-179-74613,504-4,399-384-386-112-6,455-1,6312,471-4,776-1,142-449